Pharma's Almanac

31 Articles Available

0 2

Financial Results

Samsung Biologics Reports First Quarter 2022 Financial Results

PR-M04-22-14

Automated Visual Inspection

Advancing Visual Inspection of Printed Pharmaceutical Materials

PAO-03-022-CL-24

Column: New Drug Watch

Alzheimer Drug Still Controversial

PAO-03-022-NI-04

Column: Technology

mRNA Technology: Is the Long Path Behind Leading to Endless Successes Ahead?

PAO-03-022-NI-02

Recombinant Antibody Production

HEK Cells vs. CHO Cells in Recombinant Antibody Production: What's the Better Choice

PAO-03-022-CL-22

Biomanufacturing

Unique Vector Expression Technologies for Boosting Protein Production in E. coli

PAO-02-022-CL-16

Cell Culture

Changing the Future of Cell Culture and Accelerating Next-Generation Therapies

PAO-02-022-CL-20

Gene Therapy Analytics

Overcoming Analytical Challenges for Gene Therapies

PAO-02-022-CL-14

COVID-19 Vaccines

Will the Second Wave of COVID-19 Vaccines Have the Improved Properties Needed to End the Pandemic?

PAO-03-022-NI-05

Remote Auditing

Will Remote Pharma GMP Auditing Continue Post-COVID?

PAO-02-022-CL-21

Process Validation

Streamlining Process Validation for Drug Substance Manufacturing

PAO-02-022-CL-19

Sterile

Sterile Injectables Device and Packaging Trends

PAO-02-022-NI-01

Neurodegenerative Diseases

Pioneering Nanocatalysis to Revolutionize Treatments for Neurodegenerative Diseases

PAO-01-22-CL-06

Solubility

The Limitless Potential of Thin Film Freezing

PAO-01-22-CL-04

Rare Disease Clinical Trials

Rare Disease Patients Benefit from Clinical Trial Flexibility

PAO-02-022-CL-03

Excipients

Enabling Stable, High-Viscosity Injectable Drug Products with New Excipient Combinations

PAO-01-22-CL-02

Antibody Therapeutics

Developing New Antibody Therapeutics for COVID-19 and Beyond

PAO-01-22-CL-01

COVID-19 Vaccines

The Global Immunization Disparity

PAO-02-022-CL-04

Oncology

Changing the Paradigm of Cancer Drug Discovery and Development with Plants

PAO-02-022-CL-02

Viral Vector Manufacturing

Optimizing Yields, Tech Transfer, and the Supply Chain for Viral Vector Manufacturing

PAO-02-022-CL-01

Cell Therapy

Expanding Access to Cell Therapies with a Patient-Centric Focus

PAO-02-022-CL-12

Neurodegenerative Diseases

Uncovering New Drug Targets for Neurological Diseases

PAO-02-022-CL-10

Viral Vectors

Smart Scale-Up: Expanding Viral Vectors With Microcarrier Bead Technology

PAO-02-022-CL-09

Respiratory Diseases

Developing a Novel Anti-Inflammatory for Patients with Severe Asthma

PAO-02-022-CL-13

0 2

Q12022

31 Articles Available

Can't find what you're looking for? Try our advanced search.

Financial Results

Samsung Biologics Reports First Quarter 2022 Financial Results

Automated Visual Inspection

Advancing Visual Inspection of Printed Pharmaceutical Materials

Column: New Drug Watch

Alzheimer Drug Still Controversial

Column: Technology

mRNA Technology: Is the Long Path Behind Leading to Endless Successes Ahead?

Recombinant Antibody Production

HEK Cells vs. CHO Cells in Recombinant Antibody Production: What's the Better Choice

Biomanufacturing

Unique Vector Expression Technologies for Boosting Protein Production in E. coli

Cell Culture

Changing the Future of Cell Culture and Accelerating Next-Generation Therapies

Gene Therapy Analytics

Overcoming Analytical Challenges for Gene Therapies

COVID-19 Vaccines

Will the Second Wave of COVID-19 Vaccines Have the Improved Properties Needed to End the Pandemic?

Remote Auditing

Will Remote Pharma GMP Auditing Continue Post-COVID?

Process Validation

Streamlining Process Validation for Drug Substance Manufacturing

Sterile

Sterile Injectables Device and Packaging Trends

Neurodegenerative Diseases

Pioneering Nanocatalysis to Revolutionize Treatments for Neurodegenerative Diseases

Solubility

The Limitless Potential of Thin Film Freezing

Rare Disease Clinical Trials

Rare Disease Patients Benefit from Clinical Trial Flexibility

Excipients

Enabling Stable, High-Viscosity Injectable Drug Products with New Excipient Combinations

Antibody Therapeutics

Developing New Antibody Therapeutics for COVID-19 and Beyond

COVID-19 Vaccines

The Global Immunization Disparity

Oncology

Changing the Paradigm of Cancer Drug Discovery and Development with Plants

Viral Vector Manufacturing

Optimizing Yields, Tech Transfer, and the Supply Chain for Viral Vector Manufacturing

Cell Therapy

Expanding Access to Cell Therapies with a Patient-Centric Focus

Neurodegenerative Diseases

Uncovering New Drug Targets for Neurological Diseases

Viral Vectors

Smart Scale-Up: Expanding Viral Vectors With Microcarrier Bead Technology

Respiratory Diseases

Developing a Novel Anti-Inflammatory for Patients with Severe Asthma